Pharmaceuticals, Biotechnology and Life Sciences
SMPT token holder will allow them to benefit from the inherent valuationgrowth of SPLP’s intellectual property portfolio
Based on EpimAb’sglobally filed first application, this patent broadly covers bispecificantibodies obtained utilizing the company’s FIT-Ig®technology in a composition of matter claim.
In this pilot project, the Susmed system uses blockchain technology, which isexpected to be more cost-effective than conventional methods inmonitoring of clinical researches and ensuring data accuracy duringmonitoring.
The global anticoagulants reversal drugs market expected to expand at aCAGR of 15.3% from 2018 to 2026, owing to the approval of blockbusterdrugs in recent years and strong pipeline driving the market.
DUBLIN–(BUSINESS WIRE)–The “Anterior Uveitis – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…
DUBLIN–(BUSINESS WIRE)–The “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to…
DUBLIN–(BUSINESS WIRE)–The “Drugs of Abuse Testing: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. Report Scope An…
Global Markets to 2023 with Abbott Laboratories, Bayer Healthcare, GlaxoSmithKline, Merck & Co, Pfizer and Sanofi at the Forefront
Shionogi presented data suggest cefiderocol shows a high potential for treating infections caused by themost difficult to treat Gram-negative (GN) bacteria collected fromacross Europe, including multidrug-resistant strains.